Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoying Gu

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|July 18, 2021
In-hospital complications associated with COVID-19Xiaoying Gu, Bin Cao
Lancet (London, England)|February 27, 2022
Understanding of COVID-19 from infection-fatality ratioXiaoying Gu, Bin Cao
Lancet (London, England)|November 21, 2021
Long-term effects on survivors with COVID-19 - Authors' replyLixue Huang, Xiaoying Gu, Bin Cao
Cells|April 30, 2021
Abnormal Crosstalk between Endothelial Cells and Podocytes Mediates Tyrosine Kinase Inhibitor (TKI)-Induced NephrotoxicityXiaoying Gu, Su Zhang, Ti Zhang
Frontiers in Medicine|July 6, 2026
Family cohesion and adaptability in heart failure: an APIMeM analysis of symptom perception and spousal caregiving on patient self-careYan Yang, Jianhua Shi, Xiaoying Gu
Lancet (London, England)|February 19, 2020
Full spectrum of COVID-19 severity still being depicted - Authors' replyXiaoying Gu, Bin Cao, Jianwei Wang
Ebiomedicine|February 22, 2024
Authors' reply to Letter regarding "Probing Long COVID through a Proteomic Lens: a Comprehensive Two-Year Longitudinal Cohort Study of Hospitalised Survivor"Xiaoying Gu, Catherine C L Wong, Bin Cao
The Lancet. Respiratory Medicine|June 13, 2022
A glimpse into long COVID and symptoms - Authors' replyLixue Huang, Xiaoying Gu, Hui Zhang, et al.
Lancet (London, England)|April 6, 2024
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' replyXiaoying Gu, Lixue Huang, Hui Zhang, et al.
Open Forum Infectious Diseases|August 25, 2025
Effects of Baloxavir Marboxil Plus Neuraminidase Inhibitor vs Neuraminidase Inhibitor in High-risk Patients Hospitalized With Severe Influenza: A Post Hoc Analysis of the Flagstone TrialMengwei Yan, Xiaoying Gu, Yeming Wang, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|July 18, 2021
In-hospital complications associated with COVID-19Xiaoying Gu, Bin Cao
Lancet (London, England)|February 27, 2022
Understanding of COVID-19 from infection-fatality ratioXiaoying Gu, Bin Cao
Lancet (London, England)|November 21, 2021
Long-term effects on survivors with COVID-19 - Authors' replyLixue Huang, Xiaoying Gu, Bin Cao
Cells|April 30, 2021
Abnormal Crosstalk between Endothelial Cells and Podocytes Mediates Tyrosine Kinase Inhibitor (TKI)-Induced NephrotoxicityXiaoying Gu, Su Zhang, Ti Zhang
Frontiers in Medicine|July 6, 2026
Family cohesion and adaptability in heart failure: an APIMeM analysis of symptom perception and spousal caregiving on patient self-careYan Yang, Jianhua Shi, Xiaoying Gu
Lancet (London, England)|February 19, 2020
Full spectrum of COVID-19 severity still being depicted - Authors' replyXiaoying Gu, Bin Cao, Jianwei Wang
Ebiomedicine|February 22, 2024
Authors' reply to Letter regarding "Probing Long COVID through a Proteomic Lens: a Comprehensive Two-Year Longitudinal Cohort Study of Hospitalised Survivor"Xiaoying Gu, Catherine C L Wong, Bin Cao
The Lancet. Respiratory Medicine|June 13, 2022
A glimpse into long COVID and symptoms - Authors' replyLixue Huang, Xiaoying Gu, Hui Zhang, et al.
Lancet (London, England)|April 6, 2024
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' replyXiaoying Gu, Lixue Huang, Hui Zhang, et al.
Open Forum Infectious Diseases|August 25, 2025
Effects of Baloxavir Marboxil Plus Neuraminidase Inhibitor vs Neuraminidase Inhibitor in High-risk Patients Hospitalized With Severe Influenza: A Post Hoc Analysis of the Flagstone TrialMengwei Yan, Xiaoying Gu, Yeming Wang, et al.
Pageof 11